GARLAND JASON K (CFO) sold 2.7% of their position (530.00 shares) of REPLIGEN CORP on the open market
Open‑market sale worth $79.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/17/2026ACC: 0001193125-26-307925
-530.00
Net shares
Net seller
$79.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
530.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−530.00
Price / share
$150.00
Trade value
$79.50K
% of position
2.7%
7/16/2026
19.36K→18.83K
Total
Net shares
−530.00
Net value
-$79.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/16/2026 | S · Sale | −530.00 | $150.00 | $79.50K | 2.7% | 19.36K | 18.83K |
| Total | −530.00 | -$79.50K | ||||||
Derivative Transactions0
No derivative transactions reported